Viewing StudyNCT06422403



Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06422403
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-21
First Post: 2024-05-15

Brief Title: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Sponsor: National University Hospital Singapore
Organization: National University Hospital Singapore

Conditions & Keywords Data

Conditions:
Name
Carcinoma Hepatocellular
Gastric Adenocarcinoma
GastroEsophageal Cancer
Oesophageal Cancer
Non-small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Keywords:
Name View
Extended dosing interval View
Nivolumab View
Atezolizumab View
Pembrolizumab View